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1051-131 Combined Treatment With Epsilon Protein Kinase C 
Activator and Delta Protein Kinase C Inhibitor 
Ameliorates Ischemia Reperfusion Injury With 
Prolonged Ischemia in Rat Cardiac Allografts
Masashi Tanaka, Raya D. Terry, G. Kimia Mokhtari, E. Grant Hoyt, Tomoyoshi Koyanagi, 
Koichi Inagaki, Theo Kofidis, Daria Mochly-Rosen, Robert C. Robbins, Stanford 
University, Stanford, CA
Inhibition of delta protein kinase C (δPKC) and activation of epsilon PKC (εPKC) have
both been shown to limit damage from ischemia and reperfusion (I/R). Studies have per-
tained to ischemia or myocardial infarction in particular and have been conducted in cell
cultures, isolated rat heart models, or porcine models. However, whether these isozymes
can ameliorate I/R injury in the transplanted heart has not been determined. We investi-
gated the ability of PKC regulator to reduce I/R injury with prolonged ischemia in rat car-
diac allografts. Methods: Hearts of PVG rat (RT1c) were heterotopically transplanted into
ACI rats (RT1a). After cardioplegic arrest of the donor heart, the ascending aorta was
ligated, and 2 mL of εPKC activator (ψεRACK, 1.5 nmol) solution was then injected (ante-
grade coronary injection). Hearts were procured and submerged in the same drug solu-
tion (0.5 µM) for 30 or 120 min at 4°C. Before reperfusion, 1 ml of δPKC inhibitor (δV1-1,
30 nmol) solution was injected into the recipient IVC. Control animals were treated with
normal saline. Grafts were procured after 4 h of reperfusion (n = 6 each group) and ana-
lyzed for super oxide generation by the spin-trapping method; for myeloperoxidase
(MPO) activity, TNF-α, IL-1β, and MCP-1 production by ELISA; and for apoptosis by
TUNEL and by caspase-2, -3, -8, and -9 activities. Results: With 30-min ischemia, MPO
activity, TNF-α production, and caspase-9 activity decreased significantly in the PKC reg-
ulator-treated group. With 120 min-ischemia, MPO activity, TNF-α, IL-1β, MCP-1 produc-
tion, cardiomyocyte apoptosis, and caspase-2, -3 and -9 activities decreased significantly
in the PKC regulator-treated group. Super oxide generation and caspase-8 activity did
not differ significantly between the two groups with 30-min or 120-min ischemia. Conclu-
sions: Combined treatment with εPKC activator and δPKC inhibitor attenuates the I/R
injury that occurs with prolonged ischemia but does not suppress generation of super
oxide. This treatment inhibits the mitochondrial pathway on the induction of apoptosis.
These peptides may be useful in clinical transplantation for organ preservation and pre-
vention of I/R injury.
1051-132 S-Nitric Oxide-Human Serum Albumin, a Novel 
Intravenous Nitric Oxide-Donor, Minimizes I/R Injury 
After Four Hours of Ischemia in an Orthotopic Heart 
Transplant Model in the Pig
Roman Gottardi, Tomas Szerafin, Severin Semsroth, Harald Gasser, Seth Hallstroem, 
Rainald Seitelberger, Ernst Wolner, Bruno K. Podesser, University of Vienna, Vienna, 
Austria
BACKGROUND: In clinical heart transplantation the ischemic period tolerated by the
heart is still limited. Prolonged ischemia is associated with increased risk of acute and
chronic rejection. Depletion of nitric oxide (NO) is a major contributor to ischemia/reperfu-
sion (I/R) injury. We hypothesize that NO-substitution with S-Nitroso Human Serum Albu-
min (S-NO-HSA), a new physiologic NO-donor, could bridge NO-starvation during I/R
and improve hemodynamic outcome in a model of orthotopic heart transplantation in the
pig.
METHODS: Donor pigs (n=19; 37,1±6,1 kg) were monitored and randomized to treat-
ment with (1µmol/kg/h) S-NO-HSA (n=11) or HSA (n=8; control) one hour prior to explan-
tation. Hearts were harvested and stored using Bretschneider solution with addition of
10µmol/L S-NO-HSA or HSA respectively (4°C for 4 hours). Recipient pigs (n=19;
36.5±5,9 kg) were monitored and put on cardiopulmonary bypass (CPB). Donor hearts
were implanted followed by 60 min of controlled reperfusion before subsequent weaning
from CPB (epinephrine 0,4 µ/kg/h) and a follow up of two hours. Thirty min prior to esti-
mated aortic declamping, infusion with S-NO-HSA or HSA respectively started for 60 min
(0,1 µmol/kg/h).
RESULTS: At the end of S-NO-HSA infusion in donors , a decrease in heartrate, mean
arterial pressure, left ventricular systolic pressure (LVP sys) and Wedge pressure com-
pared to control was observed. During the first 15min of reperfusion, coronary flow/car-
diac output per kg bodyweight was significantly higher in the S-NO-HSA versus the HSA
group (p<0.01). During the entire follow up there was a lower wedge pressure in the treat-
ment group that reached significance after 60 min (p<0.05). LVP sys was significantly
higher in the treatment group 30 min after weaning from CPB (p<0.05) and became
highly significant after 75 min (p<0.01).
CONCLUSIONS: In a pig model of orthotopic heart transplantation with 4 hours of
ischemia S-NO-HSA significantly minimizes I/R injury and improves organ function as
shown by an improvement of myocardial perfusion during early reperfusion, a lower
wedge pressure, indicating a better diastolic function, and a better systolic function after
weaning from CPB in the S-NO-HSA group.
1051-133 Localized Combinatorial Interleukin-4 and Interleukin-10 
Gene Therapy Readjusts the Balance of Endogenous 
Th1/Th2 Cytokines and Induces the Tolerance of 
Cardiac Allografs
Hiroshi Furukawa, Kiyohiro Oshima, Thomas C. Tung, Hyde Russell, Guanggen Cui, 
Hillel Laks, Luyi Sen, UCLA Medical Center/UCLA School of Medicine, Los Angeles, CA
The balance of Th1/Th2 cytokine plays an important role in the allograft tolerance, how-
ever, its operating mechanism remains unknown. Using a functional cervical heterotopic
rabbit heart transplant model, we tested the hypothesis that liposome-mediated ex vivo
intracoronary interleukin-4 (IL-4) and IL-10 combined gene therapy may induce localized
IL-4 and IL-10 over expression that may synergistically regulates endogenous Th1/Th2
expression, which may contributes the allograft tolerance. The mean survival of cardiac
allograft was prolonged from 7± 1 days in Control Group (CG) to 14±3 days in IL-4 gene
therapy group (IL-4G), 28± 7 days in IL-10 gene therapy Group (IL-10G) and 135± 20
days in IL-4 and IL-10 combined gene therapy Group (IL-4&10G). The transgene and
exogenous protein expression in IL-4&10G reached the peak in postoperative day (POD)
5-8, and slowly reduced thereafter. The rejection score in IL-4&10G (n=15) was signifi-
cantly lower (2.2± 0.2, p<0.05) than that of CG (3.6± 0.2, n=15) and IL-10G (2.7± 0.3,
n=15) in POD3-6, and 2.0± 0.0 in POD>31. In single cytokine gene therapy caused an
excessive localized exogenous cytokine gene and protein expression which significantly
downregulated the expression of the same endogenous cytokine, IL-4 or IL-10 gene
(p<0.01), but in a certain extent upregulated the other Th2 cytokine genes expression
(p<0.01). In IL-4&10G, endogenous IL-4 and IL-10 gene expression was decreased in
the early stage, then increased at POD 18-20 and remained in a high level for a long
period of time. The expression of Th1 cytokine genes, IL-1β and TNF-α , were signifi-
cantly decreased by the synergistic inhibition of IL-4 and IL-10, and maintained in the low
level in the late stage. IFN-γ gene expression level was increased in IL-4G, decreased in
IL-10G. The slightly decreased IFN-γ gene expression level observed in the combined
gene therapy group that could be resulted from antagonistic immunoregulatory effects of
two cytokines. We conclude that localized overexpression of exogenous IL-4 and IL-10
induced by ex vivo gene transfer could act synergistically for readjusting the balance of
endogenous Th1/Th2 cytokines that may contribute to the allograft tolerance.
1051-134 Downregulation of Connexin 43 Expression in Chronic 
Cardiac Allograft Rejection
Lathasree Polavaram, Daniel Zaghi, Guanggen Cui, Hardeep Singh Ahluwalia, Luyi Sen, 
UCLA Medical Center/UCLA School of Medicine, Los Angeles, CA
Down-regulation of the major gap-junctional protein of the ventricular myocytes,
Connexin43 (Cx43), has previously been reported in heart failure due to ischemic dilated
Cardiomyopathy (ICM) and idiopathic dilated cardiomyopathy (DCM). However, whether
it is also altered in chronic cardiac allograft rejection remains unknown. In this study, left
ventricle samples from 40 patients with dilated cardiomyopathy and end-stage heart fail-
ure underwent heart transplantation were analyzed for Cx43 and Cx40 using Western
blot analysis. Fourteen patients had DCM, 12 had ICM and 14 had chronic cardiac
allograft rejection underwent re-transplantation (CAR). Actin antibody was used as an
internal control. Left ventricular samples from 6 donor hearts were used as normal con-
trol (NLC). Cx43 expression level was significantly decreased in CAR group (0.68±0.31)
compared with that in NLC (1.14±0.49, p=0.019). The down-regulation of Cx43 was also
observed in ICM (0.73±0.36, p=0.057). In DCM, Cx43 expression level was only slightly
decreased (0.85±0.32, p=0.1205). Cx40 expression was slightly increased in CAR, ICM
and DCM compared with that in NLC (p=0.14, p=0.14 and p=0.22 respectively). All the 3
groups showed increased Pulmonary Capillary Wedge Pressure (DCM: 19.92±10.82,
ICM: 22.88±10.34, CAR: 18±7), Right Atrial Pressure (DCM: 8.5±3.17, ICM: 10.11±5.77,
CAR: 13.7±5.5). ICM and DCM in addition had increased Left Ventricular End Diastolic
Diameter (LVEDD) and decreased Left Ventricular Ejection Fraction (LVEF). The
decrease of LVEDD and LVEF in CAR was only mild to moderate. There is no significant
correlation between Cx43 and LVEDD and LVEF (p>0.05). In conclusion, these results
suggest that the altered connexin expression in ventricular tissue may be related to the
inflammation in ischemic cardiomyopathy and CAR. The down-regulation of Cx43 might
be responsible for the alteration of electrical excitation and conduction in myocardium,
but may not play a major role in the hemodynamics in both ICM and CAR.
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1068-121 Impact of Myocardial Viability Assessment on the 
Beneficial Effect of Cardiac Resynchronization Therapy 
in Patients With Ischemic Cardiomyopathy
Jacopo Dalle Mule, Renzo Perelli, Marco Mazzella, Felice Martinelli, Alessandro 
Proclemer, Virginia Scarabeo, Maria Liberata Di Sipio, City Hospital Pieve di Cadore 
Cortina Auronzo, Pieve di Cadore Cortina, Italy, Ospedale San Martino, Belluno, Italy
Background we hypothesized that imaging with Thallium201 imaging for viability could
help identify patients with ischemic left ventricular (LV) systolic dysfunction under opti-
mized medical treatment and dyssynchrony who benefit from cardiac resynchronization
therapy (CRT)
Methods: we assessed viability status in 45 consecutive patients (age 64 ±7 y.o.) with LV
EF <= 35%, QRS >= 120 ms, NYHA class 3 or 4, using SPECT Thallium201 stress, early
and 24-h redistribution imaging with a 20-segment model before CRT with biventricular
pacing (BiV), measured EF, inter- and intra-ventricular synchrony conduction delay with
gated radionuclide ventriculography , LV End Diastolic Volume Indices (LVEDVI) with
echocardiography before and 6 months after BiV
Results: 
Patients with <= 5 scarred segments on Thallium201 imaging (Group A) demonstrated
improvement of LVEF at 6 months (from 29 ±5% to 36 ±5%, p<0.0001), 21/23 (91%) had
an EF increase >5 units, NYHA class (from 3.3 ±0.5 to 2.5 ±0.5, p<0.0001), reverse
remodelling (LVEDVI decreased from 99 ±17 ml/m2 to 86 ±16 ml/m2, p<0.0001).
Conversely, patients with >5 scarred segments (Group B) failed to improve in LVEF (30
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±4% vs 31 ±5%), 18/22 (82%) had not an EF increase >5 % (p<0.0001 vs Group A),
NYHA class (from 3.5 ±0.5 to 3.2 ±0.8) and exhibited ongoing remodelling (LVEDVI
increased from 106 ±12 ml/m2 to 111 ±8 ml/m2, p=0.04)
The number of scarred segments was directly related (R2 0.52, p<0.0001) while that of
ischemic segments was inversely related to the change in EF (R2 0.46, p<0.0001).
The degree of interventricular dyssynchrony (difference in LV and right ventricular (RV)
mean phase angles) did not change from baseline to the final visit in Group B (11 ±17 vs
12 ±9), while it improved in Group A (13 ±17 vs 9 ±14; p<0.01). The degree of intraven-
tricular dyssynchrony (standard deviation of the mean phase angle) significantly
improved for LV in Group A (54 ±18 vs 51 ±19; p=0.04) but did not change in the LV (57
±14 vs 56 ±19) in Group B.
Conclusion:
Treatment with BiV in patients with ischemic cardiomyopathy and a limited extension of
scarred myocardium improves contractile synchrony, both inter- and LV intraventricular,
EF, quality of life and determines reverse remodelling of the LV
1068-122 Human Fat Tissue-Derived Stem Cells Show 
Cardiomyocytic Differentiation After Coculture
Kai Pinkernell, Christian Valina, William C. Claycomb, Jakob Reiser, R. Edward 
Newsome, Jr., Eckhard Alt, Tulane University, School of Medicine, New Orleans, LA, 
Louisiana State University, New Orleans, LA
Introduction: Cells isolated from subcutaneous fat tissue (SFT) can give rise to cells
from all three germ layers. So far differentiation into a cardiomyocyte (CM) lineage by
means of co-culturing has not been shown for cells isolated from human SFT. The acces-
sibility and obtainable cell numbers would make SFT an excellent source of cells for tis-
sue repair after myocardial infarction. Methods: CM from neonatal rat hearts were
isolated on day 1 after birth, digested with Collagenase (10mg/ml) and cultured for 1 day
under standard conditions. SFT from patients undergoing liposuction was collected and
digested with Collagenase for 90 minutes to obtain a single cell suspension. Cells were
plated under standard conditions and transfected with a lentivirus encoding eGFP. SFT
cells were then co-cultured with the neonatal rat CM in a 1:1 ratio. FACS analysis of
adherent SFT cells was done at day 1 and 5 prior to co-culture for CD34, CD45, CD105,
and CD117. Immunohistochemistry of cardiac specific Titin, Troponin T and eGFP of co-
cultured cells was done after 14 days or total RNA was harvested and an RT-PCR was
performed. Results: More than 1.3x106 cells/gram could be isolated routinely from SFT
and 30% did adhere to tissue culture plastic. A FACS analysis of the adhering SFT cells
showed an expression of CD 34 (48% +/- 9) and CD45 (6%+/-2) after 1 day in culture
which dropped to undetectable levels after 5 days. CD105 expression was 50% (+/-8, day
1) and increased to 97% (+/-2, day 5). CD117 could not be detected at any time. The co-
cultures were dispersed after 14 days and re-plated. Immunohistochemistry staining
showed dual positivity of SFT for eGFP and Titin but not for Troponin T. This was con-
firmed in the RT-PCR reaction with human specific Primers for Titin that do not cross
react with the rat CM. The RNA expression level in the CM and SFT coculture was 11 fold
above control (corrected for GAPDH). Conclusion: SFT cells show the predominantly
endothelial cell marker CD105 after 5 days in culture and are void of CD34,45 or CD117.
Direct cell-cell contact through co-culture between SFT cells and rat CM leads to an early
cardiomyocytic phenotype that expresses the sarcomeric protein Titin as shown by
immunohistochemistry and RT-PCR.
1068-123 Akinetic Segments of Myocardial Infarction Contain 
Contracting Myocytes: A Finite Element Model Study
Alan B.C. Dang, Julius M. Guccione, Jacob M. Mishell, Peng Zhang, Arthur W. Wallace, 
Robert C. Gorman, Joseph H. Gorman, III, Mark B. Ratcliffe, San Francisco Veterans 
Affairs Medical Center, San Francisco, CA, University of California, San Francisco, San 
Francisco, CA
Background:Infarcted segments of myocardium demonstrate a range of functional impair-
ment. The properties that determine the severity of dysfunction are not fully understood.
Using a finite element model, we sought to better define the relative contributions of pas-
sive material properties (stiffness) versus active properties (contracting myocytes) in
determining regional wall motion. We tested the hypothesis that in order for a segment to
be akinetic and not dyskinetic, it must contain contracting myocytes. Methods: Using two-
dimensional echocardiographic images from a reperfused ovine anteroapical infarct, we
developed a three-dimensional finite element mesh of the left ventricle. The model
describes both diastolic material properties defined by a constant, C, and systolic myo-
cardial material properties defined by isometric tension, Tmax. A reduction in the ability of
the infarcted region to develop active stress was accomplished by scaling the parameter
Tmax to represent the percentage of contracting myocytes between 0% and 100%. The
simulated change in wall thickness between end-diastole and end-systole was measured
using the fractional change of average radial strain (RS). Akinesis was defined as an
average RS between -0.01 and +0.01, where a more positive or negative value repre-
sents hypokinesis or dyskinesis, respectively. The diastolic and systolic properties neces-
sary to produce akinesis were determined using an iterative process.We then modeled
an infarct with no contracting myocytes and increased the diastolic stiffness required for
akinesis until RS fell between -0.01 and +0.01. Results: As stiffness, C, was increased
from normal (0.876 kPa) to ten times normal (10 kPa), the percentage of Tmax necessary
to achieve RS between -0.01 and +0.01 increased from 20-50 %. When the percentage
of contracting myocytes was assumed to be zero, a stiffness of C=250 kPa was neces-
sary to achieve akinesis. Conclusion: In this finite element model of left ventricular myo-
cardial infarction, if wall stiffness is less than 250 times normal, the presence of
contracting myocytes in the infarct zone is necessary to prevent dyskinetic wall motion.
1068-124 Nonviral FasL Protects Allogeneic Myoblasts Against 
Cell Death in Cardiomyogenesis
Yoshihisa Morimoto, Jamie M. Bergen, Bryce H. Davis, Ewout-Jan van den Bos, Doris A. 
Taylor, Duke University Medical Center, Durham, NC
Background: FasL, which promotes T-cell apoptosis through interaction with the death
receptor Fas, has been proposed to immunoprotect allotransplanted cells. However, suc-
cess with this strategy has been limited in part due to inflammatory side effects of viral
vectors. We hypothesize that overexpression of FasL in myoblasts via a non-viral vector
will provide protection of allotransplanted cells in heart.
Methods: C2C12 myoblasts were stably transfected with FasL and co-cultured with acti-
vated T-cells to determine FasL activity. T-cell apoptosis was examined by annexin V
expression. In vivo, control animals received untransfected DAPI-labelled myoblasts
(2x106), while treated animals (FasL group) received transfected labeled myoblasts
where 25% expressed FasL. Myoblasts were injected into cryoinjured myocardium, the
kidney capsule or subcutaneously (n=12 each). We evaluated DAPI-positive cell survival
and engraftment by histology at 1 hour and 3, 10 or 14 days post-injection.
Results: FasL transfected myoblasts induced a fourfold higher apoptosis rate in T-cells
than untreated myoblasts in vitro (23.0±2.51% vs 7.05±3.93%, P<0.001). In vivo, FasL
protected allogenic cells after injection into cryoinjured myocardium up to 14 days
(21±8.1/HPF vs 8.9±9.1 control, P<0.05). Concurrently, the maximum infarct diameter
was reduced (0.25±0.02 vs 0.29±0.03 mm; P<0.05) and infarct wall thickness was
increased (0.11±0.03 vs 0.07±0.03 mm; P<0.05). Similarly, FasL cells protected allo-
genic cells at 1h, 3d and 10d after subcutaneous injection as compared to controls
(251±6.0, 232±7.1 and 231±6.8 /HPF for FasL vs. 49±2.6, 0, 0 /HPF for controls,
P<0.001). Surprisingly, FasL did not protected allogenic cells after injection under the kid-
ney capsule.
Conclusion: Functional FasL, delivered non-virally, can more than double survival of allo-
genic cells after transplantation into injured myocardium or subcutaneously. FasL might
be a useful tool in allogenic cell therapy.
1068-125 Cyclic Stretch of Adult Human Mesenchymal Stem Cells 
Induces Expression of Early Cardiac and Neuronal 
Genes
Sunil Rangappa, Andrew S. Wechsler, J. Yasha Kresh, Drexel University College of 
Medicine, Philadelphia, PA
Background: Human mesenchymal stem cells have shown to be plastic and amenable
to transformation into cardiomyocytes. Myocardial regeneration using direct injection of
stem cells into infarcted myocardium results in low yield of differentiated cardiomyocytes.
Alternately, stem cells have been preprogrammed using chemicals, growth factors, and
co-culture of cells into cardiomyocytes in vitro. We explored the role of cyclic stretch on
human mesenchymal stem cells (hMSCs) as a stimulus to promote transdifferentiation.
Methods: hMSC were cultured in 6 well plates and subjected to programmable square
cyclic stretch at 1 Hz using the Flexercell system with 4% and 8% elongation of cells
alternating every 12 hours for 7 days in a humidified incubator with 5% CO2 at 37oC. Total
RNA was isolated from the stretched hMSC and unstretched control experiments using
microarray (Hu133A gene chips, Affymetrix Inc) and lineage specific gene expression
was studied. Genes were profiled in triplicate for cardiogenic, adipogenic, neurogenic,
osteogenic and skeletal lineage.
Results: The data was normalized and lineage specific genes were analyzed using
Gene Spring V.5.0. Induction of synaptobrevin, macrotubule associated protein (MAP-2),
and Galactocerebroside genes indicating early neurogenic lineage was observed, in
addition there was also concurrent expression of Connexin-43 and BMP-2 indicative of
early cardiogenic lineage. In contrast, there was no expression of adipogenic, osteogenic
and skeletal genes.
Conclusions: These data suggest that adult human bone marrow stem cells are plastic
and mechanical stretch bioengineers hMSC transdifferentiation to early cardiogenic and
neurogenic lineage. This technique of preprogramming stem cells in vitro could poten-
tially be used to increase high yield of lineage specific cells before cellular cardiomyo-
plasty.
1068-126 Cultured Adipose Tissue-Derived Stromal Cells Express 
the Stem Cell Marker CD34 and Show Evidence of 
Differentiation Into a Cardiomyocyte Phenotype
Jalees Rehman, Rafat Siddiqui, Jingling Li, Dmitry Traktuev, Stephanie Merfeld-Clauss, 
Keith L. March, Indiana University, School of Medicine, Indianapolis, IN
Background: Autologous cell therapy using pluripotent cells for cardiac repair and
regeneration in patients with cardiomyopathy is limited by the fact that the required cell
numbers often exceed the number of available pluripotent cells. We have recently shown
that a substantial proportion of non-adipocyte stromal cells in adipose tissue express the
stem/progenitor cell marker CD34. We therefore examined whether adipose stromal cells
(ASCs) would retain this marker in culture and whether they could differentiate into a car-
diomyocyte phenotype in vitro.
Methods: Subcutaneous adipose tissue biopsies or lipospirates were obtained from vol-
unteers. The stromal fraction cells were cultured in EBM-2 or EGM-2 medium (Clonetics-
Cambrex). The expression of CD34 was assessed on days 2, 4, 6 and 8 by flow cytome-
try. To assess differentiation of ASCs, they were labeled with the red fluorescent dye DiI
(Molecular Probes) and added to culture wells containing neonatal rat cardiomyocytes
(CMCs). The co-culture was observed for four days to identify spontaneously beating
cells. At the end of the co-culture period, cells were fixed and stained for cardiac-specific
alpha-actinin and the nuclear stain DAPI.
Results: The expression of the stem/progenitor cell marker CD34 on human ASCs was
present at consistently high levels during the first week of culture (Day 2: 95%, Day 4:
91%, Day 6: 89%, Day 8: 77%). Multiple ASCs showed evidence of spontaneous beating
